Apollon Founder, Dr. Stephen Barnhill is a medical doctor with 35 years’ experience as Chairman and CEO of numerous publicly traded and private companies specialising in laboratory medicine, biotechnology, and pharmaceuticals. He was an early pioneer in the use of artificial intelligence (machine learning) techniques in medicine, primarily in the field of cancer diagnostics. Dr. Barnhill is an inventor on more than 40 international patents on artificial intelligence and his patents were part of the Intellectual Property portfolio that won MDB Capital’s MICO Award for most disruptive IP portfolio out of 1,600 publicly traded companies. Some of Dr. Barnhill’s early AI patents were acquired by Johnson and Johnson.

Dr. Fritsche is a world-renowned Clinical Chemist and former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at The University of Texas, MD Anderson Cancer Center in Houston, Texas for 41 years. He has published over 200 peer-reviewed scientific papers, invited articles and book chapters. Dr Fritsche served as a consultant to the National Cancer Institute (NCI), the Expert Panel for developing Tumour Marker Practice Guidelines for the American Society of Clinical Oncology (ASCO) from its inception until his retirement from MD Anderson Cancer Center, the Laboratory Practice Guidelines Committee for the National Academy of Clinical Biochemistry, and the Editorial Board of six international scientific journals, He was awarded the Johnson & Johnson Award for Outstanding Research & Contributions to Clinical Biochemistry, the Abbott-ISOBM Award for Outstanding research in oncology the and the Morton K Schwartz Award for Outstanding Cancer Research.

Nick is a founding member of Apollon Formularies, Inc., a US corporation formed in 2014 to study and understand the benefits of medical cannabis to patients with varying medical conditions. In 2015, Nick was a key part of the team that oversaw the implementation of Apollon Formularies international expansion into Jamaica to lever off federal legislation allowing medical cannabis research and development for treating patients. Nick resided in Jamaica where he assisted in the roll out of Apollon Formularies Jamaica Ltd which has grown into a vertically integrated fully licensed medical cannabis company (licensed by the Cannabis Licensing Authority (CLA).

Nick is an oil gas executive with over 19 years’ experience across a wide range of corporate roles in and around the oil gas industry including M&A, business development, financing, commercial, investor relations and operational functions Nicholas started his career in banking with roles at Morgan Stanley (energy investment banking) and RBS (structured energy lending debt advisory) before joining the oil gas industry working for AIM listed Valiant Petroleum plc, LSE listed Salamander Energy plc and AIM listed Faroe Petroleum Plc Nicholas is currently Business Development Director and member of the executive team at AIM listed Longboat Energy plc He has MA Hons degree from the University of St Andrews in Ancient History.

Dr. Stephen Barnhill is a medical doctor with 35 years’ experience as Chairman and CEO of numerous publicly traded and private companies specialising in laboratory medicine, biotechnology, and pharmaceuticals. He was an early pioneer in the use of artificial intelligence (machine learning) techniques in medicine, primarily in the field of cancer diagnostics. Dr. Barnhill is an inventor on more than 40 international patents on artificial intelligence and his patents were part of the Intellectual Property portfolio that won MDB Capital’s MICO Award for most disruptive IP portfolio out of 1,600 publicly traded companies. Some of Dr. Barnhill’s early AI patents were acquired by Johnson and Johnson.

Dr. Fritsche is a world-renowned Clinical Chemist and former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at The University of Texas, MD Anderson Cancer Center in Houston, Texas for 41 years. He has published over 200 peer-reviewed scientific papers, invited articles and book chapters. Dr Fritsche served as a consultant to the National Cancer Institute (NCI), the Expert Panel for developing Tumour Marker Practice Guidelines for the American Society of Clinical Oncology (ASCO) from its inception until his retirement from MD Anderson Cancer Center, the Laboratory Practice Guidelines Committee for the National Academy of Clinical Biochemistry, and the Editorial Board of six international scientific journals, He was awarded the Johnson & Johnson Award for Outstanding Research & Contributions to Clinical Biochemistry, the Abbott-ISOBM Award for Outstanding research in oncology the and the Morton K Schwartz Award for Outstanding Cancer Research.

With over fifteen years in the cannabis industry, Jeff has become a leading expert in volatile and nonvolatile extraction, method development, lab design, cultivation and the overall business of cannabis. Founder of RELM Labs , later evolving into W vapes. They built the company ,W vapes, to one of the biggest brands in the industry, in three states before their successful exit. He has also developed multiple medical cannabis products, including “Tommy’s Oil”, developed for Tommy Chong products via RELM, medicinal tinctures, capsules and vapes for Apollon Formularies Jamaica and has won 27 first place awards for his extracts and products, (Chalice Cup for best vape cartridge, 5 Hempcon awards including The Dab cup and Champions cup, 6 Local Sesh Awards for best oil, highest cbd oil, best new product and most potent thc oil, 6 awards for Edibles List magazine best of 2018, Abracadabs best oil and 2019 Jack Herer cup Jamaica for best solvent based extract). Since 2017, Jeff has worked alongside the Apollon team bringing his skill set to Dr. Barnhill's global brand as well as a team member of AI Pharmaceuticals in their cancer research studies.

Former General Secretary of the Jamaican People's National Party (PNP) from 2014-2016. Chairman and Founding Member of the National Alliance for the Legalization of Ganja. Project Manager, Founding Member of the Cannabis Commercial and Medicinal Task Force Programme. Director and Founding Member of the Ganja Growers and Producers Association of Jamaica. Chairman of the Jamaican Wellness and Health Network.

Stephen was a Co-Founder and President of Apollon Formularies, Inc. in the US established in 2014. He was instrumental in the international expansion of Apollon Formularies to Jamaica in 2015 starting Apollon Formularies Jamaica, Ltd and obtaining a suite of vertical medical cannabis licenses from the Cannabis License Authority (CLA) including Cultivation Research and Development, Processing, and Retail Therapeutic allowing Apollon Formularies Jamaica to become a federally legal medical cannabis operation in Jamaica. Stephen was a Co-Founder and President of Doc’s Place international, a medical resort in Negril, Jamaica where international patients can stay while being treated by Apollon Formularies Jamaica’s team of Jamaican licensed medical doctors. He was involved in the expansion of Apollon to Europe and as COO of Apollon Formularies, Ltd in London, UK, he assisted in the transformation to a publicly traded company, Apollon Formularies, plc, trading on the Aquis Exchange in London. Stephen is also Founder and CEO of CBev Ventures, Inc., a medical cannabis beverage company offering the High Spirits brand of drinks.

Stene joined Apollon in December 2020 as Head of Corporate Development. He started his career in the Navy where he qualified as a South African Navy Diver in 1992. After leaving the Navy he started a long career spanning 20 years in Real Estate and had the good fortune to acquire a wide range of expertise in Property Development, Real Estate Finance, Debt and Equity structuring and Corporate Finance. He brings substantial Director level operational experience in both the corporate and entrepreneurial sectors where he has a strong track record in assisting new ‘start-ups’ implement successful strategic growth plans across various sectors. His career included the delivery of multiple projects for Standard Bank premises, as an independent consultant for the Industrial and Commercial Bank of China – at the time a Forbes no.1 Company (2013)

Dr Dingle Spence is a licensed Jamaican physician specialising in Clinical Oncology, Radiation Therapy, and Palliative Care Medicine for the past 25 years. She continues to work in the public sector at the Hope Institute and Kingston Public Hospitals and is an Associate Lecturer at the University of the West Indies. Dr Spence is cofounder of the nonprofit organization the Jamaica Cancer Care and Research Institute (JACCRI) (https://www.jaccri.org/) and is on the Board of Directors of the International Association for Hospice and Palliative Medicine. She is also a consultant expert to the International Atomic Energy Agency (IAEA) and currently sits on two Lancet Commissions dedicated to improving cancer care and health care globally.

A general medical practitioner involved in holistic practice, focusing on health and wellness and prevention of disease, providing general, primary medical care for all age groups...infant to elderly.

Dr Hall is a Neurosurgeon, Board-Certified and Fellowship Trained in brain and spine surgery. He has been practicing medicine for over 25 years. He earned his Doctor of Medicine degree from McGill University Faculty of Medicine and one of the first five physicians Certified by the state of Florida to recommend medical cannabis. Dr Hall has pioneered, developed, and practiced minimally invasive and endoscopic surgical techniques for the brain and spine since 1993. He has performed research in spinal electrophysiology at the University of Miami as part of the Miami Project to Cure Paralysis. Dr Hall has faculty appointments at Nova Southeastern University College of Medicine and the Herbert Wertheim Florida International University College of Medicine. Dr Hall has also lectured and taught students from Barry University and the University of Alabama. He is the President-Elect of the Miami-Dade Chapter of the National Medical Association, and he is also a member of the Congress of Neurological Surgeons, American Association of Neurological Surgeons, and the Florida Neurosurgical Society. Dr. Hall is actively involved with outreach programs and performs charity medical care in several countries.

Dr. Fritsche is a world-renowned Clinical Chemist and former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at The University of Texas, MD Anderson Cancer Center in Houston, Texas for 41 years. He has published over 200 peer-reviewed scientific papers, invited articles and book chapters. Dr Fritsche served as a consultant to the National Cancer Institute (NCI), the Expert Panel for developing Tumour Marker Practice Guidelines for the American Society of Clinical Oncology (ASCO) from its inception until his retirement from MD Anderson Cancer Center, the Laboratory Practice Guidelines Committee for the National Academy of Clinical Biochemistry, and the Editorial Board of six international scientific journals, He was awarded the Johnson & Johnson Award for Outstanding Research & Contributions to Clinical Biochemistry, the Abbott-ISOBM Award for Outstanding research in oncology the and the Morton K Schwartz Award for Outstanding Cancer Research.

Dr Dawes is a General Surgeon with additional expertise in Bariatrics with a fellowship in Bariatrics and Minimally Invasive Surgery at the Santa Casa Hospital in Curitiba, Brazil. From 2012-2015 he worked at the Spanish Town Hospital as a Senior Registrar in General Surgery and was Senior Medical Officer at the Savanna-La-Mar Public General Hospital. Dr Dawes is a Fellow of the American College of Surgeons (FACS).